Načítá se...
Orphan drug development in China – Turning challenges into opportunities
Of over 7,000 known rare diseases, only 5% currently have an available treatment option worldwide. Moreover, the vast majority of rare disease patients in China have no access to treatment due to limited availability and the lack of appropriate infrastructure in China's healthcare system. Despi...
Uloženo v:
| Vydáno v: | Intractable Rare Dis Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116871/ https://ncbi.nlm.nih.gov/pubmed/27904831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01025 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|